Stocks:
5,169
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.78T
24h Vol:
$12.20B
Dominance:
MSFT:4.81%
Stocklytics Platform
LIXT
Lixte Biotechnology Holdings
LIXTW
4 / 100
$0.09arrow_drop_up40.62%$0.02

Performance History

Stocklytics logo
Key Stats
Open$0.09
Prev. Close$0.06
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap-
PE Ratio-
LOWHIGH
Day Range0.09
0.09
52 Week Range0.03
0.13
Ratios
P/B Ratio0.00
Revenue-
Operating M. %0.00%
Earnings$0.00
Earnings Growth %19.41%
EBITDA Margin %-
ROE %-111.07%
EPS-

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$350.70
24H (%)arrow_drop_down1.47%
24H ($)-$5.23
MARKET CAP$177.47B
PRICE$359.00
24H (%)arrow_drop_up0.27%
24H ($)$1.00
MARKET CAP$50.03B
Placeholder
PRICE$24.00
24H (%)arrow_drop_down0.41%
24H ($)-$0.10
MARKET CAP$37.12B
PRICE$23.24
24H (%)arrow_drop_up0.18%
24H ($)$0.04
MARKET CAP$36.57B

About Lixte Biotechnology Holdings (LIXTW)

No data available
Sector
-
Industry
-
CEO
-
Headquarters
-
Employees
0
Exchange
NASDAQ
add Lixte Biotechnology Holdings to watchlist

Keep an eye on Lixte Biotechnology Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Lixte Biotechnology Holdings's (LIXTW) price per share?

The current price per share for Lixte Biotechnology Holdings (LIXTW) is $0.09. The stock has seen a price change of $0.03 recently, indicating a 40.62% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Lixte Biotechnology Holdings (LIXTW)?

For Lixte Biotechnology Holdings (LIXTW), the 52-week high is $0.14, which is 54.44% from the current price. The 52-week low is $0.03, the current price is 200% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Lixte Biotechnology Holdings (LIXTW) a growth stock?

Lixte Biotechnology Holdings (LIXTW) has shown an average price growth of 0.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Lixte Biotechnology Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Lixte Biotechnology Holdings (LIXTW) stock price performance year to date (YTD)?

As of the latest data, Lixte Biotechnology Holdings (LIXTW) has a year-to-date price change of 91.49%. Over the past month, the stock has experienced a price change of 80%. Over the last three months, the change has been 1.81%. Over the past six months, the figure is 20.16%.

help
Is Lixte Biotechnology Holdings (LIXTW) a profitable company?

Lixte Biotechnology Holdings (LIXTW) has a net income of -$5.09M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$5.09M. Furthermore, the EBITDA is $0.

help
What is the market capitalization of Lixte Biotechnology Holdings (LIXTW)?

Lixte Biotechnology Holdings (LIXTW) has a market capitalization of . The average daily trading volume is 27.24K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level